| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5883025 | Clinical Lymphoma Myeloma and Leukemia | 2013 | 5 Pages |
Abstract
The use of aggressive chemoimmunotherapy in combination with the withdrawal of immunosuppression approach yields excellent results and should be prospectively studied in a multiinstitutional setting.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Nikolai Podoltsev, Bingnan Zhang, Xiaopan Yao, Ivan Bustillo, Yanhong Deng, Dennis L. Cooper,